Researcher awarded $12 million for a stem cell trial to improve outcomes of young blood cancer patients
Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.
The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.
Researchers have found that old skeletal stem cells contribute to bone fragility and poor healing in mice, but that a stem cell-boosting gel may help restore function.
Researchers have identified the mechanism of scar formation in skin and demonstrated in mice a way to make wounds heal with normal skin instead of scar tissue.
A single protein is a master regulator of mouse muscle function during aging, a Stanford study finds. Blocking this protein increased muscle strength and endurance in old animals. It may play a role in age-related muscle weakening in humans.
Video: Viral DNA is crucial to human development
REMS seminars are held on Thursdays at 1pm